Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-110,113
Closed -$4.53M 160
2018
Q4
$4.53M Buy
110,113
+219
+0.2% +$8.98K 0.1% 75
2018
Q3
$4.5M Sell
109,894
-1,894
-2% -$76.6K 0.08% 122
2018
Q2
$4.44M Buy
111,788
+757
+0.7% +$29.1K 0.07% 124
2018
Q1
$4.15M Buy
111,031
+16,854
+18% +$681K 0.07% 126
2017
Q4
$4.03M Buy
+94,177
New +$3.76M 0.06% 125

Other funds holding HOLX

Cambiar Investors's HOLX Position: Q1 2019 in Review

Cambiar Investors sold out of Hologic (HOLX) in Q1 2019, closing a stake of 110,113 shares — an estimated $4.53M sold.

Cambiar Investors first reported a position in HOLX in Q4 2017 and held it in 5 quarters. The position peaked at $4.53M in Q4 2018. 467 funds tracked by Wall St. Rank hold HOLX as of Q1 2019.

  • Cambiar Investors reported no remaining Hologic position as of Q1 2019 after selling out during the quarter.
  • Cambiar Investors sold 110,113 Hologic shares in Q1 2019, an estimated $4.53M.
  • Cambiar Investors first reported a position in Hologic in Q4 2017 and held it in 5 quarters.
  • Cambiar Investors's Hologic position peaked at $4.53M in Q4 2018.
  • 467 funds tracked by Wall St. Rank held Hologic as of Q1 2019.

Based on Cambiar Investors's 13F filing for Q1 2019, filed 8 May 2019.